Faecalibacterium prausnitzii promotes intestinal epithelial IL-18 production through activation of the HIF1α pathway
- PMID: 38163085
- PMCID: PMC10755969
- DOI: 10.3389/fmicb.2023.1298304
Faecalibacterium prausnitzii promotes intestinal epithelial IL-18 production through activation of the HIF1α pathway
Abstract
Introduction: Intestinal epithelial cells produce interleukin-18 (IL-18), a key factor in promoting epithelial barrier integrity. Here, we analyzed the potential role of gut bacteria and the hypoxia-inducible factor 1α (HIF1α) pathway in regulating mucosal IL18 expression in inflammatory bowel disease (IBD).
Methods: Mucosal samples from patients with IBD (n = 760) were analyzed for bacterial composition, IL18 levels and HIF1α pathway activation. Wild-type Caco-2 and CRISPR/Cas9-engineered Caco-2-HIF1A-null cells were cocultured with Faecalibacterium prausnitzii in a "Human oxygen-Bacteria anaerobic" in vitro system and analyzed by RNA sequencing.
Results: Mucosal IL18 mRNA levels correlated positively with the abundance of mucosal-associated butyrate-producing bacteria, in particular F. prausnitzii, and with HIF1α pathway activation in patients with IBD. HIF1α-mediated expression of IL18, either by a pharmacological agonist (dimethyloxallyl glycine) or F. prausnitzii, was abrogated in Caco-2-HIF1A-null cells.
Conclusion: Butyrate-producing gut bacteria like F. prausnitzii regulate mucosal IL18 expression in a HIF1α-dependent manner that may aid in mucosal healing in IBD.
Keywords: Faecalibacterium; HIF1α; HoxBan in vitro coculture system; IBD; IL-18; epithelial-bacteria interaction; intestine.
Copyright © 2023 Fagundes, Bravo-Ruiseco, Hu, Kierans, Weersma, Taylor, Dijkstra, Harmsen and Faber.
Conflict of interest statement
GD received research grant from Royal DSM and speaker’s fees from Janssen Pharmaceuticals, Pfizer and Abbvie. RW acted as consultant for Takeda and received unrestricted grants from Takeda, Johnson & Johnson, Tramedico and Ferring, and received speaker’s fee from MSD, Abbvie and Janssen Pharmaceuticals. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Bao C. H., Wang C. Y., Li G. N., Yan Y. L., Wang D., Jin X. M., et al. . (2019). Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome. World J. Gastroenterol. 25, 4696–4714. doi: 10.3748/wjg.v25.i32.4696 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
